Qifang Bi (@QifangB) profile picture

infectious disease epidemiologist | formerly @JHIDDynamics & @sarahcobey lab

Baltimore, MD
Joined April 2015
Photo by Qifang Bi (@QifangB)Photo by Qifang Bi (@QifangB)Photo by Qifang Bi (@QifangB)
Thrilled to announce that our data science (modeling/analytics) jobs are now live for the @cdcgov Center for Forecasting and Outbreak Analytics: closing June 3 so apply now!
9
186
11
318
Partners In Health announced that its founder, Dr. Paul Farmer, unexpectedly passed away today in his sleep while in Rwanda. Dr. Farmer was 62 years old. He is survived by his wife, Didi Bertrand Farmer, and their three children. 1/🧵
881
3,896
3,718
13,939
Postdoc (Chicago, United States) Modeling immunity to respiratory viruses, the effects of immunity on transmission, and population-level epi-evo forecasts with @sarahcobey at @UChicago More details: iddjobs.org/jobs/modeling-im…
Working with @KatieMG, @PhilAArevalo, @QifangB, @LaurenRMcGough, @CJRussoJr, @Diana_DVC1 + @Marcos___Vieira we review how differences in early influenza infection histories lead to birth-year associated differences in susceptibility (cohort + imprinting effects)
Out online now: An Opinion piece by Rachel Oidtman and colleagues discussing the importance of path-dependent cohort effects underlying influenza immune escape. @LaurenRMcGough @QifangB @KatieMG @RJOidtman sciencedirect.com/science/ar…
4
13
26
Congrats to @QifangB @andrewazman et al. on our new paper in @LancetMicrobe using serology to understand practical performance of RT-PCR for #COVID19 . Even rigorous protocols miss ~1/3 of cases. Timing matters a lot, and missed cases often asymptomatic. authors.elsevier.com/sd/arti…
Our team has reviewed 14 papers on #COVID vaccine phase 1-3 trials, including those produced by @moderna_tx, @BioNTech_Group/@pfizer,& @OxfordVacGroup/@AstraZeneca. All results to date have shown that the vaccines are safe and have very few side effects, including in older adults
2
29
5
55
1) Finally this it out. It took a few years of my life to get this into clinical trials (with the help of many others). A first step towards the clinical development of universal influenza virus vaccines. With Adolfo Garcia-Sastre, Peter Palese. nature.com/articles/s41591-0…
86
524
218
2,747
We had two preprints out last week. They might seem unrelated, but have lots to do with each other. In this thread I will outline the results and what they have to do with recent discussions around testing. @JHIDDynamics doi.org/10.1101/2020.09.02.2… doi.org/10.1101/2020.09.01.2… (1/16)
4
51
14
89
If you have not yet bookmarked this page or followed @JHSPH_NCRC, do so now! Drs. @EmilyGurley3 and @KateGrabowski are world-class epidemiologists who are leading an amazing team in timely and critical reviews of the important #COVID19 scientific papers. ncrc.jhsph.edu/
It is rare to find large primary data of cases and close contacts, for which RT-PCR testing was universal in the early phase of an outbreak. It was a tremendous amount of effort to collect this dataset. Credit to Shenzhen CDC and Peng Cheng Laboratory for making it happen. 1/n
Wonderful to see this this work on #COVID19 transmission using contact tracing data finally peer reviewed and out in @TheLancetInfDis. Congrats to @QifangB and all of our other collaborators for their incredible hard work on this paper.
1
8
47
7/n See our preprint for the near complete clinical trajectory of COVID-19 among cases in Shenzhen. We observed significant difference in clinical trajectory by sex for those over the age of 60. Underlying conditions can't explain the difference.
1
1
1
Replying to @JHIDDynamics
@JHIDDynamics folks have done some detailed analysis of case reports to get an estimate of the incubation period from public reports. Analysis at github.com/HopkinsIDD/ncov_i…. Nice work: @salauer_biostat @khgrantz @qulu_zheng @hanmered @QifangB @ForrestKJones (1/3)
1
17
3
28